| Kathryn Leigh Melvin, CNM, APRN | |
|
2200 E Parrish Ave Ste 201, Owensboro, KY 42303-1449 | |
| (270) 926-3700 | |
| (270) 926-0368 |
| Full Name | Kathryn Leigh Melvin |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 6 Years |
| Location | 2200 E Parrish Ave Ste 201, Owensboro, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285149864 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 3012739 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Owensboro Health Regional Hospital | Owensboro, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Owensboro Health Medical Group Inc | 0648255034 | 358 |
News Archive
Novartis announced today that the US Food and Drug Administration has approved the dual combination bronchodilator Utibron Neohaler (indacaterol/glycopyrrolate) inhalation powder for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated to treat asthma or sudden symptoms of COPD.
New data presented at the International Liver CongressTM today show the existence of novel interactions between T cells and hepatocytes that are regulated by HCV infection, providing a novel understanding of how HCV persists in the liver.
After visiting Ghana on a recent tour to examine poverty reduction strategies and progress on the Millennium Development Goals (MDGs), Jeffrey Sachs, director of the Earth Institute at Columbia University and "one of the world's most prominent development economists, says Ghana is proving to be one of the strongest performers on the [MDGs] in Africa and unlike some of its African counterparts is likely to fulfill them by the 2015 deadline," the Christian Science Monitor reports.
Two subset analyses from the landmark HORIZONS-AMI trial show that the anticoagulant bivalirudin lowers major bleeding and cardiac death versus the combination of heparin and a GP IIb/IIIa inhibitor in patients with ST-segment myocardial infarction (STEMI) who have disease of the left anterior descending artery (LAD), while in STEMI patients at highest risk for death, bivalirudin also confers the greatest mortality benefit.
› Verified 4 days ago
| Entity Name | Owensboro Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235518242 PECOS PAC ID: 0648255034 Enrollment ID: O20040621000818 |
News Archive
Novartis announced today that the US Food and Drug Administration has approved the dual combination bronchodilator Utibron Neohaler (indacaterol/glycopyrrolate) inhalation powder for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated to treat asthma or sudden symptoms of COPD.
New data presented at the International Liver CongressTM today show the existence of novel interactions between T cells and hepatocytes that are regulated by HCV infection, providing a novel understanding of how HCV persists in the liver.
After visiting Ghana on a recent tour to examine poverty reduction strategies and progress on the Millennium Development Goals (MDGs), Jeffrey Sachs, director of the Earth Institute at Columbia University and "one of the world's most prominent development economists, says Ghana is proving to be one of the strongest performers on the [MDGs] in Africa and unlike some of its African counterparts is likely to fulfill them by the 2015 deadline," the Christian Science Monitor reports.
Two subset analyses from the landmark HORIZONS-AMI trial show that the anticoagulant bivalirudin lowers major bleeding and cardiac death versus the combination of heparin and a GP IIb/IIIa inhibitor in patients with ST-segment myocardial infarction (STEMI) who have disease of the left anterior descending artery (LAD), while in STEMI patients at highest risk for death, bivalirudin also confers the greatest mortality benefit.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn Leigh Melvin, CNM, APRN Po Box 23229, Owensboro, KY 42304-3229 Ph: (270) 688-1330 | Kathryn Leigh Melvin, CNM, APRN 2200 E Parrish Ave Ste 201, Owensboro, KY 42303-1449 Ph: (270) 926-3700 |
News Archive
Novartis announced today that the US Food and Drug Administration has approved the dual combination bronchodilator Utibron Neohaler (indacaterol/glycopyrrolate) inhalation powder for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated to treat asthma or sudden symptoms of COPD.
New data presented at the International Liver CongressTM today show the existence of novel interactions between T cells and hepatocytes that are regulated by HCV infection, providing a novel understanding of how HCV persists in the liver.
After visiting Ghana on a recent tour to examine poverty reduction strategies and progress on the Millennium Development Goals (MDGs), Jeffrey Sachs, director of the Earth Institute at Columbia University and "one of the world's most prominent development economists, says Ghana is proving to be one of the strongest performers on the [MDGs] in Africa and unlike some of its African counterparts is likely to fulfill them by the 2015 deadline," the Christian Science Monitor reports.
Two subset analyses from the landmark HORIZONS-AMI trial show that the anticoagulant bivalirudin lowers major bleeding and cardiac death versus the combination of heparin and a GP IIb/IIIa inhibitor in patients with ST-segment myocardial infarction (STEMI) who have disease of the left anterior descending artery (LAD), while in STEMI patients at highest risk for death, bivalirudin also confers the greatest mortality benefit.
› Verified 4 days ago
Susan M Johnson, CNM, APRN Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 2200 E Parrish Ave Ste 201, Owensboro, KY 42303 Phone: 270-926-3700 Fax: 270-926-0368 | |
Lisa C Wimsatt, ARNP CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 2851 New Hartford Rd # Rd, Owensboro, KY 42303 Phone: 270-688-6035 | |
Marilu Adams, ARNP Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1600 Breckenridge St, Daviess County Health Center, Owensboro, KY 42303 Phone: 270-686-7744 Fax: 270-926-8677 |